论文部分内容阅读
本文对239例重度心力衰竭(NYHA4级)并随机接受 enalapril 和安慰剂治疗的患者,在治疗前和治疗后6周分别测定血液激素活性,旨在研究心力衰竭患者的激素活性及其与预后的关系。先前的研究(CONSEN-SUS)报告称 enalapril 能显著降低心衰患者
In this study, 239 patients with severe heart failure (NYHA class 4) randomized to enalapril and placebo were tested for hemo-hormonal activity before and 6 weeks after treatment in order to study the hormonal activity of patients with heart failure and their association with prognosis relationship. A previous study (CONSEN-SUS) reported that enalapril significantly reduced heart failure